COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection Uses, Dosage, Side Effects and more
COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection is an intradermal injection currently being investigated in the clinical trial NCT03348670 (Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP) (AP-TP-Bio)).
| Trade Name | COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection |
| Generic | COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection |
| COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection Other Names | COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection, COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
